A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing VIR-2482, a new treatment aimed at preventing the flu (influenza A). It focuses on healthy adults aged 18 to less than 65 years who do not have risk factors for serious flu complications. The treatment likely works by boosting the immune system or directly fighting the flu virus.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive VIR-2482 or placebo to evaluate efficacy, safety, and tolerability in preventing influenza A
Follow-up
Participants are monitored for safety and effectiveness after treatment, including adverse events and laboratory abnormalities
What Are the Treatments Tested in This Trial?
Interventions
- Placebo
- VIR-2482
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vir Biotechnology, Inc.
Lead Sponsor